Drug Company Up 36%, FDA Accepts New Drug Application (SOMX)

Symbols: SOMX
Share

PicksThatMove.com reports that the FDA has given Somaxon Pharmaceuticals Inc. (NASDAQ: SOMX) a new Prescription Drug User Fee Act date of December 4th for its drug Silenor. The FDA accepted the company’s resubmitted New Drug Application for Silenor, its drug to treat insomnia.

Somaxon, (SOMX) a pharmaceutical company, is surging in today’s trading session, posting a 36% gain today, up $1.08 to $4.08. The company’s stock has jumped 456% since June, according to the website.


 
 
< Previous
Cramer Bullish On State Street, Steel Names
Next >
ETF Plays On Amazon And eBay (HHH, FDN)
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust

Special Offers:
Quick Cash Advance